Gilead says head of commercial operations to retire

... month. Young, who plans to step down on Feb. 4, has held the top commercial post for the world's leading maker of HIV/AIDS medicines since 2004. During his tenure Gilead's annual sales grew from $1.24 billion in 2004 to about $11 billion in 2013. ...

http://www.reuters.com/article/2014/01/06/gilead-young-idUSL2N0KG1Y520140106?feedType=RSS&feedName=rbssHealthcareNews